Polymeric Biomaterials Market Synopsis:
Polymeric Biomaterials Market Size Was Valued at USD 52.10 Billion in 2023, and is Projected to Reach USD 219.88 Billion by 2032, Growing at a CAGR of 17.35% From 2024-2032.
Polymeric Biomaterials Market is the segment of biomedical fields that involves processing and utilization of polymeric for biomedical purposes. These biomaterials are intended to function and communicate with the biological environment, and are used in several implanted medical tools, controlled release systems, and tissue scaffolding. They are usually employed due to their versatility, compatibility with living tissues and possibility to be adjusted for particular species of medicine.
The market for Polymeric Biomaterials is rapidly strengthening due to progressing health care sector and the rising need for biocompatible materials in operations. Polymeric biomaterials have become indispensable for fabrication of various medical devices including prosthetics, implantable devices, drug delivery systems and tissue engineering scaffolds due to properties like flexibility, high strength, and ease of tailoring for specific application. Such materials are designed to provide body-like properties of actual tissues and therefore suitable for use in regenerative medicine as well as other treatments.
One of the factors influencing this market is the rising trend of the geriatric population, this means that more often people’s require additional medical interventions such as joint replacement surgery or a cardiac procedure. In today’s enamored world of advanced healthcare systems and shorter hospital stays, polymeric biomaterials are making their contribution to enhance the quality of treatments. Another advantage for the market is the increasing use of minimally invasive procedures that utilize polymers in sutures, wound dressings and medical adhesives. Moreover, the rising research activities to synthesize new biodegradable polymers minimized the risks associated with implantable devices that are more permanent than applicators.
Polymeric Biomaterials are also affected by regulation concerning the safety and effectiveness of medical material. Authorities such as governments and health organizations are making sure that materials used in applications that are medical are biocompatible and / or high performing, which of course has both its challenges and its opportunities for manufacturers. Nonetheless, these challenges remain as hurdles to the use of polymeric biomaterials as new technologies arise guided by the rising uses in orthopaedics, neurology, dental care, and more.
Polymeric Biomaterials Market Trend Analysis:
Shift Towards Biodegradable Polymers
- Most of the new trends agreed by the Polymeric Biomaterials Market are associated with the increasing market demand for biodegradable polymers. Such substances are finding wide acceptance in medical applications since it can disintegrate safely from the body upon completion of their therapeutic function. PHA, PLA, PGA and their copolymers are employed in drug delivery systems, sutures, and tissue engineering scaffolds eliminating the need for further operations to remove implants.
- For this reason, this trend is fueled by two major factors: consumer demand for less invasive procedures and the durability of medical procedures. Since most patients struggle with chronic diseases, and the healthcare providers’ main goal is to achieve this goal without the possible complications resulting from a non-degradable material, biodegradable polymers can be helpful. Further, regulatory agencies continue to encourage the adoption of biodegradable materials which is also pushing development in this segment.
Expanding Applications in Tissue Engineering
- Tissue engineering is set to be one promising application in the polymeric biomaterials market for the envisaged growth. They outlined how polymers are finding application in tissue engineering as support structures on which to promote the formation of new tissues and organs – a field that will be critical in regenerative medicine. These polymeric scaffolds form a base onto which cells can adhere and multiple tissue loss, organic transplant is not necessarily required.
- Prospects for stem cell therapy and regenerative medicine are in focus so, it can be predicted that with the growth of new technologies, tissue engineers will look for newer polymeric biomaterials. Such an ability to regenerate tissues for multiple purposes - skin grafts for burn victims, cartilage regeneration for the orthopedic sector among others is a great market opportunity. Several polymers are being synthesised for different applications and for improving characteristics such as increased porosity, biodegradability and compatibility with cell.
Polymeric Biomaterials Market Segment Analysis:
Polymeric Biomaterials Market is Segmented on the basis of Product, Application, and Region.
By Product, Polyurethanes segment is expected to dominate the market during the forecast period
- Polymeric biomaterials are classified into a number of categories and all the materials within these categories possess unique characteristics and uses. Thus, Attempts have been made to use PLA and PGA in biodegradable medical applications such a suture and tissue engineering scaffolds. These polymers have a tendency of breaking down in the body, thus minimizing the cases of follow up operations. Polyurethanes traditionally have been characterized as mechanically strong and flexible of a variety of cardiovascular applications, including stents and heart valves.
- Polytetrafluoroethylene PTFE also known by its tradename Teflon is employed non reactive material for implants and grafts. The polyaryletheretherketone (PEEK) is immensely preferred due its high tensile strength and low coefficient of wear, rendering it suitable in orthopedic applications. Another biodegradable polymer which is widely applied in sutures as a material is polydioxanone. Taken all together, these materials meet a very wide spectrum of clinical needs and continued advances are directed toward enhancing performance.
By Application, Cardiology segment expected to held the largest share
- Biomaterials mainly incorporated polymers have number of uses in various fields of medicine. Soft tissue is also employed for nerve grafting and also for procedures in the brain, in neurology. In cardiovascular application, polymeric biomaterials are used on applications such as stents, heart valves, and vascular grafts. Examples of their usage are dental implants and the membranes used in periodontal regeneration known as guided tissue regeneration. Polymers are used in the facial implantation and in reconstruction surgical procedures where the face is involved.
- Orthopedics is one of the biggest sub-markets within this application, polymeric biomaterial being applied with joint replacements and bone fixation devices. Some of the fields of application are contact lens and corneal implant. Biodegradable dressings and sutures used in the treatment of wounds also employ polymeric biomaterials in large measure. These diverse applications demonstrate the significance of the polymeric in present day medication field.
Polymeric Biomaterials Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America has been identified to be the largest market for Polymeric Biomaterials due to its strong and developed health care facilities and increased focus on research and development. Specifically, the United States possesses a large number of development enterprises and research institutions involved in medical device technology and biomaterials. The market in this region is propelled by a stable healthcare industry backed by government support for hi-tech products and the flow of massive amounts of capital into the biomedical sector.
- Moreover, the high statistic of cases of chronic diseases with an aging population creates a massive need for better and more sophisticated medical solutions, which involve the incorporation of polymeric biomaterials. The regulation of biomaterials is also well developed in North America, so the new types of biomaterials correspond to all the security requirements, thus promoting the organization of the innovative market but maintaining stability.
Active Key Players in the Polymeric Biomaterials Market:
- BASF SE (Germany)
- Evonik Industries AG (Germany)
- Corbion NV (Netherlands)
- Covestro AG (Germany)
- Celanese Corporation (United States)
- DSM Biomedical (Netherlands)
- Victrex plc (United Kingdom)
- Foster Corporation (United States)
- PolyOne Corporation (United States)
- Ashland Global Holdings Inc. (United States)
- Solvay S.A. (Belgium)
- SABIC (Saudi Arabia)
- Other Active Players
|
Polymeric Biomaterials Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 52.10 Billion |
|
Forecast Period 2024-32 CAGR: |
17.35% |
Market Size in 2032: |
USD 219.88 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Application |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the Report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Polymeric Biomaterials Market by Product
4.1 Polymeric Biomaterials Market Snapshot and Growth Engine
4.2 Polymeric Biomaterials Market Overview
4.3 Polylactic Acid
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Polylactic Acid: Geographic Segmentation Analysis
4.4 Polyglycolic Acid
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Polyglycolic Acid: Geographic Segmentation Analysis
4.5 Polyurethanes
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Polyurethanes: Geographic Segmentation Analysis
4.6 Polytetrafluoroethylene
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Polytetrafluoroethylene: Geographic Segmentation Analysis
4.7 Polyaryletheretherketone
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Polyaryletheretherketone: Geographic Segmentation Analysis
4.8 Polydioxanone
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Polydioxanone: Geographic Segmentation Analysis
4.9 Others
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Others: Geographic Segmentation Analysis
Chapter 5: Polymeric Biomaterials Market by Application
5.1 Polymeric Biomaterials Market Snapshot and Growth Engine
5.2 Polymeric Biomaterials Market Overview
5.3 Neurology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Neurology: Geographic Segmentation Analysis
5.4 Cardiology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Cardiology: Geographic Segmentation Analysis
5.5 Dental
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Dental: Geographic Segmentation Analysis
5.6 Plastic Surgery
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Plastic Surgery: Geographic Segmentation Analysis
5.7 Orthopaedics
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Orthopaedics: Geographic Segmentation Analysis
5.8 Ophthalmology
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Ophthalmology: Geographic Segmentation Analysis
5.9 Wound Care
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Wound Care: Geographic Segmentation Analysis
5.10 Others
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Polymeric Biomaterials Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BASF SE (GERMANY)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 EVONIK INDUSTRIES AG (GERMANY)
6.4 CORBION NV (NETHERLANDS)
6.5 COVESTRO AG (GERMANY)
6.6 CELANESE CORPORATION (UNITED STATES)
6.7 DSM BIOMEDICAL (NETHERLANDS)
6.8 VICTREX PLC (UNITED KINGDOM)
6.9 FOSTER CORPORATION (UNITED STATES)
6.10 POLYONE CORPORATION (UNITED STATES)
6.11 ASHLAND GLOBAL HOLDINGS INC. (UNITED STATES)
6.12 SOLVAY S.A. (BELGIUM)
6.13 SABIC (SAUDI ARABIA)
6.14 OTHER ACTIVE PLAYERS
Chapter 7: Global Polymeric Biomaterials Market By Region
7.1 Overview
7.2. North America Polymeric Biomaterials Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Product
7.2.4.1 Polylactic Acid
7.2.4.2 Polyglycolic Acid
7.2.4.3 Polyurethanes
7.2.4.4 Polytetrafluoroethylene
7.2.4.5 Polyaryletheretherketone
7.2.4.6 Polydioxanone
7.2.4.7 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Neurology
7.2.5.2 Cardiology
7.2.5.3 Dental
7.2.5.4 Plastic Surgery
7.2.5.5 Orthopaedics
7.2.5.6 Ophthalmology
7.2.5.7 Wound Care
7.2.5.8 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Polymeric Biomaterials Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Product
7.3.4.1 Polylactic Acid
7.3.4.2 Polyglycolic Acid
7.3.4.3 Polyurethanes
7.3.4.4 Polytetrafluoroethylene
7.3.4.5 Polyaryletheretherketone
7.3.4.6 Polydioxanone
7.3.4.7 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Neurology
7.3.5.2 Cardiology
7.3.5.3 Dental
7.3.5.4 Plastic Surgery
7.3.5.5 Orthopaedics
7.3.5.6 Ophthalmology
7.3.5.7 Wound Care
7.3.5.8 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Russia
7.3.6.2 Bulgaria
7.3.6.3 The Czech Republic
7.3.6.4 Hungary
7.3.6.5 Poland
7.3.6.6 Romania
7.3.6.7 Rest of Eastern Europe
7.4. Western Europe Polymeric Biomaterials Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Product
7.4.4.1 Polylactic Acid
7.4.4.2 Polyglycolic Acid
7.4.4.3 Polyurethanes
7.4.4.4 Polytetrafluoroethylene
7.4.4.5 Polyaryletheretherketone
7.4.4.6 Polydioxanone
7.4.4.7 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Neurology
7.4.5.2 Cardiology
7.4.5.3 Dental
7.4.5.4 Plastic Surgery
7.4.5.5 Orthopaedics
7.4.5.6 Ophthalmology
7.4.5.7 Wound Care
7.4.5.8 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 The Netherlands
7.4.6.5 Italy
7.4.6.6 Spain
7.4.6.7 Rest of Western Europe
7.5. Asia Pacific Polymeric Biomaterials Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Product
7.5.4.1 Polylactic Acid
7.5.4.2 Polyglycolic Acid
7.5.4.3 Polyurethanes
7.5.4.4 Polytetrafluoroethylene
7.5.4.5 Polyaryletheretherketone
7.5.4.6 Polydioxanone
7.5.4.7 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Neurology
7.5.5.2 Cardiology
7.5.5.3 Dental
7.5.5.4 Plastic Surgery
7.5.5.5 Orthopaedics
7.5.5.6 Ophthalmology
7.5.5.7 Wound Care
7.5.5.8 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Polymeric Biomaterials Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Product
7.6.4.1 Polylactic Acid
7.6.4.2 Polyglycolic Acid
7.6.4.3 Polyurethanes
7.6.4.4 Polytetrafluoroethylene
7.6.4.5 Polyaryletheretherketone
7.6.4.6 Polydioxanone
7.6.4.7 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Neurology
7.6.5.2 Cardiology
7.6.5.3 Dental
7.6.5.4 Plastic Surgery
7.6.5.5 Orthopaedics
7.6.5.6 Ophthalmology
7.6.5.7 Wound Care
7.6.5.8 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkiye
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Polymeric Biomaterials Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Product
7.7.4.1 Polylactic Acid
7.7.4.2 Polyglycolic Acid
7.7.4.3 Polyurethanes
7.7.4.4 Polytetrafluoroethylene
7.7.4.5 Polyaryletheretherketone
7.7.4.6 Polydioxanone
7.7.4.7 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Neurology
7.7.5.2 Cardiology
7.7.5.3 Dental
7.7.5.4 Plastic Surgery
7.7.5.5 Orthopaedics
7.7.5.6 Ophthalmology
7.7.5.7 Wound Care
7.7.5.8 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
|
Polymeric Biomaterials Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 52.10 Billion |
|
Forecast Period 2024-32 CAGR: |
17.35% |
Market Size in 2032: |
USD 219.88 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Application |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the Report: |
|
||
